Two-Hour test could curb superbug spread in hospitals
NCT ID NCT07663110
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study aims to see if a rapid 2-hour test for carbapenem-resistant bacteria (CPE) can reduce person-to-person spread in hospitals better than the standard 24-hour test. Researchers will screen 16,000 adult patients admitted to hospital and track who carries CPE. They will also analyze costs to see if the faster test is worth adopting widely.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to faster screening strategies that reduce the spread of drug-resistant bacteria in hospitals and save healthcare costs.
- What could go wrong
- This is an observational study, not a treatment trial. The faster test may not significantly reduce transmission, and results may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARBAPENEM-RESISTANT ENTEROBACTERIACEAE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charing Cross Hospital
London, United Kingdom
-
St Thomas' hospital
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.